Identification of novel therapeutic target genes in acquired lapatinib-resistant breast cancer by integrative meta-analysis

Abstract

Acquired resistance to lapatinib is a highly problematic clinical barrier that has to be overcome for a successful cancer treatment. Despite efforts to determine the mechanisms underlying acquired lapatinib resistance (ALR), no definitive genetic factors have been reported to be solely responsible for the acquired resistance in breast cancer. Therefore, we performed a cross-platform meta-analysis of three publically available microarray datasets related to breast cancer with ALR, using the R-based RankProd package. From the meta-analysis, we were able to identify a total of 990 differentially expressed genes (DEGs, 406 upregulated, 584 downregulated) that are potentially associated with ALR. Gene ontology (GO) function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of the DEGs showed that "response to organic substance" and "p53 signaling pathway" may be largely involved in ALR process. Of these, many of the top 50 upregulated and downregulated DEGs were found in oncogenesis of various tumors and cancers. For the top 50 DEGs, we constructed the gene coexpression and protein-protein interaction networks from a huge database of well-known molecular interactions. By integrative analysis of two systemic networks, we condensed the total number of DEGs to six common genes (LGALS1, PRSS23, PTRF, FHL2, TOB1, and SOCS2). Furthermore, these genes were confirmed in functional module eigens obtained from the weighted gene correlation network analysis of total DEGs in the microarray datasets ("GSE16179" and "GSE52707"). Our integrative meta-analysis could provide a comprehensive perspective into complex mechanisms underlying ALR in breast cancer and a theoretical support for further chemotherapeutic studies.

A Novel IGLC2 Gene Linked With Prognosis of Triple-Negative Breast Cancer

“…Novel biomarkers have been successfully identified by genetic coexpression network (GCN) analysis in BCs (10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24). GCN is an undirected graph, where each node corresponds to a gene, and a pair of nodes is connected with an edge if there is a significant coexpression relationship between them (25).…”

Clustering, Pathway Enrichment, and Protein-Protein Interaction Analysis of Gene Expression in Neurodevelopmental Disorders

“…Pathway enrichment shows that neuronal development genes are involved in colorectal cancer, neuron death, and other diseases like leukemia and sclerosis [50]. Genes AKT1, BAD, BAX, BCL2, CASP3, CASP8, CASP9, MYC, PIK3CD, MAPK1, MAPK10, and CYCS are commonly expressed in the cluster of colorectal cancer, neuronal signaling pathway, neuronal death, amytrophic lateral aclerosis, and tuberculosis [51]. Further proteins are identified that show interaction with these proteins on the basis of protein-protein interaction study.…”

Meta-analysis of whole-genome gene expression datasets assessing the effects of IDH1 and IDH2 mutations in isogenic disease models

“…Exosomal PRSS23 is, e.g., involved in cardiovascular disease where the protease likely mediates Snail/alpha‐smooth muscle actin signalling 31 . In cancer, PRSS23 is implicated in tumor progression, and it was identified in a systematic network survey of a meta-analysis of breast cancer microarray expression data as one of six genes involved in acquired lapatinib resistance 32 . Promoter studies in breast cancer cells indicated that PRSS23 is upregulated by estrogen receptor 1 (ESR1) and that its upregulated expression contributes to cell proliferation 33 .…”